{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T13:26:40Z","timestamp":1750339600314,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11033-022-07598-5","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T14:02:47Z","timestamp":1655560967000},"page":"7731-7741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins"],"prefix":"10.1007","volume":"49","author":[{"given":"Andreia P","family":"Alves","sequence":"first","affiliation":[]},{"given":"Sandra M","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Ana C","family":"Mamede","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia C","family":"Braga","sequence":"additional","affiliation":[]},{"given":"Marco G","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Pedro F","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Filomena M","family":"Botelho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5658-5445","authenticated-orcid":false,"given":"Cl\u00e1udio J","family":"Maia","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"7598_CR1","doi-asserted-by":"publisher","unstructured":"McGlynn KA, Petrick JL, El-Serag HB (Jan. 2021) Epidemiology of Hepatocellular Carcinoma. Hepatology 73(4). no. Suppl 1doi: https:\/\/doi.org\/10.1002\/HEP.31288","DOI":"10.1002\/HEP.31288"},{"key":"7598_CR2","doi-asserted-by":"publisher","unstructured":"Petrick JL et al (2020) \u201cInternational trends in hepatocellular carcinoma incidence, 1978\u20132012,\u201d Int. J. cancer, vol.\u00a0147, no. 2, pp.\u00a0317\u2013330, doi: https:\/\/doi.org\/10.1002\/IJC.32723","DOI":"10.1002\/IJC.32723"},{"key":"7598_CR3","doi-asserted-by":"publisher","unstructured":"McGlynn KA, Petrick JL, London WT (May 2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. \u201d Clin Liver Dis 19(2):223\u2013238. doi: https:\/\/doi.org\/10.1016\/j.cld.2015.01.001","DOI":"10.1016\/j.cld.2015.01.001"},{"key":"7598_CR4","doi-asserted-by":"publisher","unstructured":"Alqahtani A, Khan Z, Alloghbi A, Ahmed TSS, Ashraf M, Hammouda DM (Sep. 2019) Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Med (Kaunas) 55(9). doi: https:\/\/doi.org\/10.3390\/MEDICINA55090526","DOI":"10.3390\/MEDICINA55090526"},{"key":"7598_CR5","doi-asserted-by":"publisher","unstructured":"Burkhart RA, Ronnekleiv-Kelly SM, Pawlik TM (Jun. 2017) Personalized therapy in hepatocellular carcinoma: Molecular markers of prognosis and therapeutic response. Surg Oncol 26(2):138\u2013145. doi: https:\/\/doi.org\/10.1016\/J.SURONC.2017.01.009","DOI":"10.1016\/J.SURONC.2017.01.009"},{"key":"7598_CR6","doi-asserted-by":"crossref","unstructured":"WARBURG O (3191) \u201cOn the origin of cancer cells.,\u201d Science, vol.\u00a0123, no. pp.\u00a0309\u201314, Feb. 1956, Accessed: Apr. 11, 2019. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13298683","DOI":"10.1126\/science.123.3191.309"},{"key":"7598_CR7","doi-asserted-by":"publisher","unstructured":"De Matteis S et al (2018) \u201cAberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities,\u201d Oxid. Med. Cell. Longev., vol. pp.\u00a01\u201313, Nov. 2018, doi: https:\/\/doi.org\/10.1155\/2018\/7512159","DOI":"10.1155\/2018\/7512159"},{"key":"7598_CR8","doi-asserted-by":"publisher","unstructured":"Du D et al (2022) \u201cMetabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma,\u201d Acta Pharm. Sin. B, vol.\u00a012, no. 2, pp.\u00a0558\u2013580, doi: https:\/\/doi.org\/10.1016\/J.APSB.2021.09.019","DOI":"10.1016\/J.APSB.2021.09.019"},{"key":"7598_CR9","doi-asserted-by":"publisher","unstructured":"Kato Y, Maeda T, Suzuki A, Baba Y (Feb. 2018) Cancer metabolism: New insights into classic characteristics. Jpn Dent Sci Rev 54(1):8\u201321. doi: https:\/\/doi.org\/10.1016\/J.JDSR.2017.08.003","DOI":"10.1016\/J.JDSR.2017.08.003"},{"key":"7598_CR10","doi-asserted-by":"publisher","unstructured":"Shokoohian B et al (2021) \u201cAdvanced therapeutic modalities in hepatocellular carcinoma: Novel insights,\u201d J. Cell. Mol. Med., vol.\u00a025, no. 18, pp.\u00a08602\u20138614, doi: https:\/\/doi.org\/10.1111\/JCMM.16875","DOI":"10.1111\/JCMM.16875"},{"issue":"4","key":"7598_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4251\/WJGO.V13.I4.197","volume":"13","author":"MC Guan","year":"2021","unstructured":"Guan MC et al (2021) Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World J Gastrointest Oncol 13(4):197\u2013215. doi: https:\/\/doi.org\/10.4251\/WJGO.V13.I4.197","journal-title":"World J Gastrointest Oncol"},{"key":"7598_CR12","doi-asserted-by":"publisher","unstructured":"Seo JH, Kim YH, Kim JS (Jan. 2008) Properties of the amniotic membrane may be applicable in cancer therapy. Med Hypotheses 70(4):812\u2013814. doi: https:\/\/doi.org\/10.1016\/j.mehy.2007.08.008","DOI":"10.1016\/j.mehy.2007.08.008"},{"key":"7598_CR13","doi-asserted-by":"publisher","unstructured":"Mamede AC, Carvalho MJ, Abrantes AM, Laranjo M, Maia CJ, Botelho MF (2012) \u201cAmniotic membrane: from structure and functions to clinical applications,\u201d Cell Tissue Res., vol.\u00a0349, no. 2, pp.\u00a0447\u2013458, Aug. doi: https:\/\/doi.org\/10.1007\/s00441-012-1424-6","DOI":"10.1007\/s00441-012-1424-6"},{"key":"7598_CR14","doi-asserted-by":"publisher","unstructured":"Mamede AC et al (Apr. 2014) Effect of amniotic membrane proteins in human cancer cell lines: an exploratory study. \u201d J Membr Biol 247(4):357\u2013360. doi: https:\/\/doi.org\/10.1007\/s00232-014-9642-3","DOI":"10.1007\/s00232-014-9642-3"},{"key":"7598_CR15","doi-asserted-by":"publisher","unstructured":"Mamede AC et al (Dec. 2015) Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma. \u201d Med Oncol 32(12):257. doi: https:\/\/doi.org\/10.1007\/s12032-015-0702-z","DOI":"10.1007\/s12032-015-0702-z"},{"issue":"5","key":"7598_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000343656","volume":"58","author":"AF Brito","year":"2012","unstructured":"Brito AF et al (2012) Hepatocellular Carcinoma and Chemotherapy: The Role of p53. Chemotherapy 58(5):381\u2013386. doi: https:\/\/doi.org\/10.1159\/000343656","journal-title":"Chemotherapy"},{"key":"7598_CR17","doi-asserted-by":"publisher","unstructured":"Liang Y, Liu J, Feng Z (Feb. 2013) The regulation of cellular metabolism by tumor suppressor p53. Cell Biosci 3(1). doi: https:\/\/doi.org\/10.1186\/2045-3701-3-9","DOI":"10.1186\/2045-3701-3-9"},{"key":"7598_CR18","doi-asserted-by":"crossref","unstructured":"Shao C et al (2004) \u201cSuppression of corneal neovascularization by PEDF release from human amniotic membranes.,\u201d Invest. Ophthalmol. Vis. Sci., vol.\u00a045, no. 6, pp.\u00a01758\u201362, Accessed: Apr. 11, 2019. [Online]. Available: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15161837","DOI":"10.1167\/iovs.03-0882"},{"key":"7598_CR19","doi-asserted-by":"publisher","unstructured":"Rato L, Alves MG, Socorro S, Carvalho RA, Cavaco JE, Oliveira PF (Feb. 2012) Metabolic modulation induced by oestradiol and DHT in immature rat Sertoli cells cultured in vitro. Biosci Rep 32(1):61\u201369. doi: https:\/\/doi.org\/10.1042\/BSR20110030","DOI":"10.1042\/BSR20110030"},{"key":"7598_CR20","doi-asserted-by":"publisher","unstructured":"Benzie IFF, Strain JJ (1996) \u201cThe ferric reducing ability of plasma (FRAP) as a measure of \u2018antioxidant power\u2019: the FRAP assay,\u201d Anal. Biochem., vol.\u00a0239, no. 1, pp.\u00a070\u201376, Jul. doi: https:\/\/doi.org\/10.1006\/ABIO.1996.0292","DOI":"10.1006\/ABIO.1996.0292"},{"key":"7598_CR21","doi-asserted-by":"publisher","unstructured":"Gomes MA, Priolli DG, Tralh\u00e3o JG, Botelho MF (2013) \u201cCarcinoma hepatocelular: epidemiologia, biologia, diagn\u00f3stico e terapias,\u201d Rev. Assoc. Med. Bras., vol.\u00a059, no. 5, pp.\u00a0514\u2013524, Sep. doi: https:\/\/doi.org\/10.1016\/j.ramb.2013.03.005","DOI":"10.1016\/j.ramb.2013.03.005"},{"key":"7598_CR22","doi-asserted-by":"publisher","unstructured":"Kang N-H et al (2012) \u201cPotential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells,\u201d Cancer Gene Ther., vol.\u00a019, no. 8, pp.\u00a0517\u2013522, doi: https:\/\/doi.org\/10.1038\/cgt.2012.30","DOI":"10.1038\/cgt.2012.30"},{"key":"7598_CR23","doi-asserted-by":"publisher","unstructured":"Magatti M, Munari S, Vertua E, Parolini O (Sep. 2012) Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. J Cell Mol Med 16(9):2208\u20132218. doi: https:\/\/doi.org\/10.1111\/j.1582-4934.2012.01531.x","DOI":"10.1111\/j.1582-4934.2012.01531.x"},{"key":"7598_CR24","doi-asserted-by":"publisher","unstructured":"Riedel R et al (Dec. 2019) Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells. Sci Rep 9(1). doi: https:\/\/doi.org\/10.1038\/S41598-019-50648-5","DOI":"10.1038\/S41598-019-50648-5"},{"key":"7598_CR25","doi-asserted-by":"publisher","unstructured":"Liu QW et al (2020) \u201cHuman amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice,\u201d J. Cell. Mol. Med., vol.\u00a024, no. 18, pp.\u00a010525\u201310541, doi: https:\/\/doi.org\/10.1111\/JCMM.15668","DOI":"10.1111\/JCMM.15668"},{"key":"7598_CR26","doi-asserted-by":"publisher","unstructured":"Mamede AC et al (Oct. 2016) \u201cOxidative Stress, DNA, Cell Cycle\/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma. \u201d Pathol Oncol Res 22(4):689\u2013697. doi: https:\/\/doi.org\/10.1007\/s12253-016-0053-x","DOI":"10.1007\/s12253-016-0053-x"},{"key":"7598_CR27","doi-asserted-by":"publisher","unstructured":"Brahimi-Horn MC, Chiche J, Pouyss\u00e9gur J (2007) \u201cHypoxia and cancer,\u201d J. Mol. Med., vol.\u00a085, no. 12, pp.\u00a01301\u20131307, Dec. doi: https:\/\/doi.org\/10.1007\/s00109-007-0281-3","DOI":"10.1007\/s00109-007-0281-3"},{"key":"7598_CR28","doi-asserted-by":"publisher","unstructured":"Alves AP et al (2019) \u201cGlycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?,\u201d Curr. Cancer Drug Targets, vol.\u00a019, no. 1, pp.\u00a026\u201340, doi: https:\/\/doi.org\/10.2174\/1568009618666180430144441","DOI":"10.2174\/1568009618666180430144441"},{"key":"7598_CR29","doi-asserted-by":"publisher","unstructured":"Gatenby RA, Gillies RJ (2004) \u201cWhy do cancers have high aerobic glycolysis?,\u201d Nat. Rev. Cancer, vol.\u00a04, no. 11, pp.\u00a0891\u2013899, Nov. doi: https:\/\/doi.org\/10.1038\/nrc1478","DOI":"10.1038\/nrc1478"},{"issue":"3","key":"7598_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1615\/CritRevEukaryotGeneExpr.2016016531","volume":"26","author":"M Zhao","year":"2016","unstructured":"Zhao M, Zhang Z (2016) Glucose Transporter Regulation in Cancer: A Profile and the Loops. Crit Rev Eukaryot Gene Expr 26(3):223\u2013238. doi: https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2016016531","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"7598_CR31","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz-Pinedo C, Ruiz-Ruiz C, Ruiz de Almod\u00f3var C, Palacios C, L\u00f3pez-Rivas A (2003) \u201cInhibition of Glucose Metabolism Sensitizes Tumor Cells to Death Receptor-triggered Apoptosis through Enhancement of Death-inducing Signaling Complex Formation and Apical Procaspase-8 Processing,\u201d J. Biol. Chem., vol.\u00a0278, no. 15, pp.\u00a012759\u201312768, Apr. doi: https:\/\/doi.org\/10.1074\/jbc.M212392200","DOI":"10.1074\/jbc.M212392200"},{"key":"7598_CR32","doi-asserted-by":"publisher","unstructured":"Brito AF et al (Sep. 2015) Fluorine-18 Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma: Correlation with Glucose Transporters and p53 Expression. J Clin Exp Hepatol 5(3):183\u2013189. doi: https:\/\/doi.org\/10.1016\/j.jceh.2015.05.003","DOI":"10.1016\/j.jceh.2015.05.003"},{"key":"7598_CR33","doi-asserted-by":"publisher","unstructured":"Amann T, Hellerbrand C (2009) \u201cGLUT1 as a therapeutic target in hepatocellular carcinoma,\u201d Expert Opin. Ther. Targets, vol.\u00a013, no. 12, pp.\u00a01411\u20131427, Dec. doi: https:\/\/doi.org\/10.1517\/14728220903307509","DOI":"10.1517\/14728220903307509"},{"issue":"1","key":"7598_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/OL.2019.11191","volume":"19","author":"H Gao","year":"2020","unstructured":"Gao H et al (2020) Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma. Oncol Lett 19(1):691\u2013699. doi: https:\/\/doi.org\/10.3892\/OL.2019.11191","journal-title":"Oncol Lett"},{"key":"7598_CR35","doi-asserted-by":"publisher","unstructured":"Moreno-S\u00e1nchez R et al (May 2012) Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells. \u201d J Cell Biochem 113(5):1692\u20131703. doi: https:\/\/doi.org\/10.1002\/jcb.24039","DOI":"10.1002\/jcb.24039"},{"key":"7598_CR36","doi-asserted-by":"publisher","unstructured":"Faloppi L et al (2016) \u201cLactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New,\u201d Biomed Res. Int., vol. pp.\u00a01\u20137, 2016, doi: https:\/\/doi.org\/10.1155\/2016\/7196280","DOI":"10.1155\/2016\/7196280"},{"key":"7598_CR37","doi-asserted-by":"publisher","unstructured":"Alves VA, Pinheiro C, Morais-Santos F, Felipe-Silva A, Longatto-Filho A, Baltazar F (Sep. 2014) Characterization of monocarboxylate transporter activity in hepatocellular carcinoma. World J Gastroenterol 20(33):11780. doi: https:\/\/doi.org\/10.3748\/wjg.v20.i33.11780","DOI":"10.3748\/wjg.v20.i33.11780"},{"key":"7598_CR38","doi-asserted-by":"publisher","unstructured":"Gao H-J et al (2015) \u201cMonocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration,\u201d J. Cancer Res. Clin. Oncol., vol.\u00a0141, no. 7, pp.\u00a01151\u20131162, doi: https:\/\/doi.org\/10.1007\/s00432-014-1888-8","DOI":"10.1007\/s00432-014-1888-8"},{"issue":"2","key":"7598_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1113\/EP088911","volume":"106","author":"F Dalouchi","year":"2021","unstructured":"Dalouchi F, Falak R, Bakhshesh M, Sharifiaghdam Z, Azizi Y, Aboutaleb N (2021) Human amniotic membrane mesenchymal stem cell-conditioned medium reduces inflammatory factors and fibrosis in ovalbumin-induced asthma in mice. Exp Physiol 106(2):544\u2013554. doi: https:\/\/doi.org\/10.1113\/EP088911","journal-title":"Exp Physiol"},{"key":"7598_CR40","doi-asserted-by":"publisher","unstructured":"Mirapoglu SL et al (Jul. 2021) Effects of Platelet Rich Plasma and Amniotic Cell Culture Medium on Wound Healing Following Experimental Animal Tracheal Injury Model: A Comparative Study. J Craniofac Surg 32(5):1937\u20131941. doi: https:\/\/doi.org\/10.1097\/SCS.0000000000007396","DOI":"10.1097\/SCS.0000000000007396"},{"key":"7598_CR41","doi-asserted-by":"publisher","unstructured":"Faridvand Y et al (Aug. 2020) Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes. Cardiovasc Toxicol 20(4):370\u2013379. doi: https:\/\/doi.org\/10.1007\/S12012-020-09564-8","DOI":"10.1007\/S12012-020-09564-8"},{"key":"7598_CR42","doi-asserted-by":"publisher","unstructured":"Wu M et al (2022) \u201cHuman Amniotic Membrane Promotes Angiogenesis in an Oxidative Stress Chronic Diabetic Murine Wound Model,\u201d Adv. wound care, doi: https:\/\/doi.org\/10.1089\/WOUND.2022.0005","DOI":"10.1089\/WOUND.2022.0005"},{"key":"7598_CR43","doi-asserted-by":"publisher","unstructured":"Goonetilleke M et al (Dec. 2021) Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis using amniotic epithelial cells. Stem Cell Res Ther 12(1). doi: https:\/\/doi.org\/10.1186\/S13287-021-02476-6","DOI":"10.1186\/S13287-021-02476-6"},{"key":"7598_CR44","doi-asserted-by":"publisher","unstructured":"Shen Y-C et al (Jan. 2013) Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. \u201d Br J Cancer 108(1):72\u201381. doi: https:\/\/doi.org\/10.1038\/bjc.2012.559","DOI":"10.1038\/bjc.2012.559"},{"key":"7598_CR45","doi-asserted-by":"publisher","unstructured":"Bonnet S et al (Jan. 2007) \u201cA mitochondria-K + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. \u201d Cancer Cell 11(1):37\u201351. doi: https:\/\/doi.org\/10.1016\/j.ccr.2006.10.020","DOI":"10.1016\/j.ccr.2006.10.020"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07598-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07598-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T18:41:24Z","timestamp":1658428884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07598-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7598"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07598-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"11 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations OF conflicting interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}